Table 2.
Measurements
| T0 (baseline testing) | T1 (midpoint testing, after 6 weeks) | T2 (endpoint testing) | T3 (3-month follow-up) |
| Venous blood sampling | Venous blood sampling | Idem T0 |
Idem T0 |
| Bioimpedance analysis |
|
||
| Echocardiography | |||
| Cardiopulmonary exercise test | |||
| Maximal strength test | |||
| Resting ECG (48 hours) | |||
| Resting blood pressure and arteriography | |||
| Panoramic ultrasound of vastus lateralis and rectus femoris | |||
| Questionnaires (SF-36, IBL-VF, PSQI) |
IBL-VF, Questionnaire on the burden and quality of life in patients with atrial fibrilation; PSQI, Pittsburgh Sleep Quality Index; SF-36, 36-item Short Form Health Survey.